feed,title,long_url,short_url
Benzinga,One Rejected BioMarin's Hemophilia Gene Therapy Goes Under FDA Review,https://benzinga.com/general/biotech/22/10/29251936/one-rejected-biomarins-hemophilia-gene-therapy-goes-under-fda-review,https://bit.ly/3MqaEgp
Benzinga,Pfizer/BioNTech's Updated Omicron Adapted COVID-19 Shot Increases Neutralizing Antibodies Above Pre-Booster Levels,https://benzinga.com/general/biotech/22/10/29251899/pfizerbiontechs-updated-omicron-adapted-covid-19-shot-increases-neutralizing-antibodies-above-pre,https://bit.ly/3rPr3l5
